Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research - United States
doi 10.1016/s0011-393x(05)00055-x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica
Hepatology
2013English

Treatment Response and Tolerability of Pegylated Interferon-Α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 Years) With Chronic Hepatitis C in Korea

Hepatitis Monthly
HepatologyInfectious Diseases
2012English

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

BMC Genomics
BiotechnologyGenetics
2014English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Decrease in Regulatory T-Cell Function in Chronic Hepatitis C Patients Receiving Pegylated-Interferon Plus Ribavirin

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2006English

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4

IOSR Journal of Pharmacy (IOSRPHR)
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy